[Solitary peritoneal carcinomatosis in prostate cancer]

Aktuelle Urol. 2007 Sep;38(5):408-9. doi: 10.1055/s-2007-959185.
[Article in German]

Abstract

Introduction: Peritoneal carcinomatosis is a rare finding in metastatic prostate cancer. In the literature peritoneal carcinomatosis is usually reported in its final stages with multiple metastases. A single peritoneal carcinomatosis with no further metastases is a very rare finding.

Case report: We report the case of a 75-year-old patient with initial ischuria. A prostate cancer could be confirmed and the further diagnostics showed no metastasis. In a transperitoneal approach for laparoscopic pelvic lymphadenectomy a peritoneal carcinomatosis from prostate cancer was proven. A complete antiandrogen therapy was started and PSA decreased for more than 14 months to a stable level of < 1 microg/L.

Conclusion: An isolated peritoneal carcinomatosis from prostate cancer is a very rare finding. The complete antiandrogen therapy is effective.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adenocarcinoma* / diagnosis
  • Adenocarcinoma* / drug therapy
  • Adenocarcinoma* / secondary
  • Adenocarcinoma* / surgery
  • Aged
  • Androgen Antagonists / therapeutic use
  • Anilides / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Follow-Up Studies
  • Goserelin / therapeutic use
  • Humans
  • Lymph Node Excision
  • Male
  • Nitriles / therapeutic use
  • Peritoneal Neoplasms / diagnosis
  • Peritoneal Neoplasms / drug therapy
  • Peritoneal Neoplasms / pathology
  • Peritoneal Neoplasms / secondary*
  • Peritoneum / pathology
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms* / diagnosis
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms* / surgery
  • Time Factors
  • Tosyl Compounds / therapeutic use
  • Transurethral Resection of Prostate
  • Treatment Outcome

Substances

  • Androgen Antagonists
  • Anilides
  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal
  • Nitriles
  • Tosyl Compounds
  • Goserelin
  • bicalutamide
  • Prostate-Specific Antigen